IP Library Granted Patent US 10,849,962
Granted Patent B2
US 10,849,962 · App. 16/171,465 · Granted Dec 1, 2020

Method and apparatus for microneedle transdermal delivery

Inventor: Martin J. D'Souza (Duluth, GA)
Assignee: THE CORPORATION OF MERCER UNIVERSITY
A61K39/00A61K9/0021A61K9/1652A61K9/5026A61K9/5036A61K9/5042A61K9/5161A61K9/5169A61K9/5192A61K31/245A61K31/46A61K31/5383A61K31/7036A61K31/7048A61K31/7088A61K31/727A61K35/747A61K39/0008A61K39/0011A61K39/095A61K39/155A61K39/165A61M5/32C12N5/0677C12N7/00C12N15/88A61K48/00A61K2039/52A61K2039/54A61K2039/55555A61K2039/55594A61K2039/57C12N2533/72C12N2533/74C12N2760/18434C12N2760/18534
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,849,962
App. No.
16/171,465
Granted
Dec 1, 2020
Kind
B2
Abstract

A method for forming microspheres containing bioactive material, comprising dissolving a polymer matrix, such as albumin or beta-cyclodextrin, in an aqueous medium in a first vessel; contacting the dissolved polymer matrix with a crosslinking agent, such as glutaraldehyde, to crosslink the polymer matrix and the crosslinking agent; neutralizing with sodium bisulfate any excess crosslinking agent remaining after crosslinking is substantially complete; solubilizing in a second vessel a bioactive material in an aqueous solution; mixing the solubilized bioactive material together with the neutralized crosslinked polymer matrix in solution to form a mixture; and, spray drying the mixture to produce nanospheres, whereby substantial bioactivity of the biomaterial is retained upon cellular uptake.

Claims (9)

1. A method for incorporating a vaccine into an orally dissolving film, comprising:

(a) preparing a polymeric solution comprising a nonorganic solvent and at least two polymers selected from the group consisting of hydroxyl-propyl methylcellulose acetate succinate, cellulose acetate phthalate polymer (CAP), ethyl cellulose, HPMC-AS, a mixture of copolymers derived from esters of acrylic and methacrylic acids, and chitosan glycol;

(b) preparing nanoparticles or microparticles of encapsulated vaccine by spray drying at a temperature higher than the boiling point of the nonorganic solvent and lower than a temperature at which the vaccine degrades a mixture of a proteinaceous vaccine material and the polymeric solution; and,

(c) casting the nanoparticles or microparticles in a film solution to form the film.

2. The method of claim 1 , wherein the film solution comprises a film forming polymer.

3. The method of claim 2 , wherein the film forming polymer comprises pea starch.

4. The method of claim 3 , wherein the film solution comprises a plasticizer.

5. The method of claim 4 , wherein the nanoparticles or microparticles comprise an adjuvant.

6. The method of claim 1 , wherein the nanoparticle or microparticle has an average particle size in a range of 1,000 nm to about 5,500 nm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2022
From: D'SOUZA, MARTIN J.
To: THE CORPORATION OF MERCER UNIVERSITY
Reel/Frame 060233/0904 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2018
From: D'SOUZA, MARTIN J.
To: THE CORPORATION OF MERCER UNIVERSITY
Reel/Frame 047335/0596 →
Continuity (3)
Continuation 16017542 · Jun 25, 2018
Continuation 14874978 · Oct 5, 2015
Related Publication 20190060426A1 · Feb 28, 2019